Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
No Data
NeuroSense Therapeutics Gets South Korean Patent for ALS Drug Candidate PrimeC
Express News | Neurosense Therapeutics - Granted South Korean Patent Covering Primec Composition for ALS
Roth MKM Keeps Their Buy Rating on Neurosense Therapeutics Ltd. (NRSN)
Sector Update: Healthcare Stocks Rise Tuesday Afternoon
NeuroSense Therapeutics Secures Japanese Patent 7857044 Covering Its Lead Drug Candidate For Treatment Of Amyotrophic Lateral Sclerosis
NeuroSense Therapeutics Advances Canadian Regulatory Talks on ALS Drug PrimeC